TESAMORELIN | Reference Standard

Metabolic Regulation, Visceral Adiposity & Endocrine Signaling Studies

Category:
Endocrinology • Metabolic Research • Body Composition • GH Axis Modulation

 

What Researchers Study

Tesamorelin is a synthetic analog of Growth Hormone–Releasing Hormone (GHRH) consisting of the first 29 amino acids of native GHRH with a stabilizing trans-3-hexenoic acid modification.

Researchers study Tesamorelin because it:

• Stimulates endogenous, pulsatile growth hormone (GH) release

• Preserves physiologic GH rhythms

• Elevates IGF-1 indirectly, rather than forcing supraphysiologic levels

• Preferentially targets visceral adipose tissue

• Minimizes proliferative risks associated with exogenous GH exposure

Tesamorelin is best understood as a GH-axis regulator, not a growth hormone itself.

 

Primary Signal Pathways Studied

• GHRH receptor activation (anterior pituitary)

• Pulsatile GH secretion

• Hepatic IGF-1 signaling

• Visceral adipose lipolysis

• Insulin sensitivity modulation

• Lipid metabolism and hepatic fat regulation

 

Why This Molecule Is Studied

Unlike direct GH administration—which creates continuous exposure and non-physiologic signaling—Tesamorelin restores upstream control of the GH axis.

This makes it uniquely valuable for studying:

• Visceral fat biology

• Metabolic syndrome

• Lipid partitioning

• Age-related GH decline

• GH–IGF signaling without excessive tissue proliferation

Tesamorelin allows researchers to observe metabolic effects without overriding endocrine feedback loops.

 

Mechanistic Overview

Tesamorelin binds GHRH receptors in the anterior pituitary, stimulating natural GH pulses. These pulses then drive downstream IGF-1 production, lipid mobilization, and metabolic adaptations.

Key outcomes observed in research models include:

• Preferential reduction of visceral (not subcutaneous) fat

• Preservation of lean mass

• Improved lipid profiles

• Reduced hepatic steatosis

• Improved insulin sensitivity

This endocrine selectivity is the defining feature of Tesamorelin.

 

Key Research Domains

1. Visceral Adiposity & Body Composition

Tesamorelin is most studied for its selective action on visceral fat depots, making it a reference compound in:

• Central obesity models

• HIV-associated lipodystrophy research

• Age-related fat redistribution studies

Notably, reductions occur without significant loss of lean mass.

2. Metabolic Syndrome & Insulin Sensitivity

Research shows Tesamorelin improves:

• Insulin sensitivity (HOMA-IR)

• Triglyceride levels

• Lipoprotein particle profiles

This positions Tesamorelin as a metabolic normalizer, not a stimulant.

3. Lipid & Cardiovascular Risk Research

Tesamorelin has demonstrated:

• Reductions in triglycerides

• Improvements in LDL particle size

• Reduced atherogenic lipid fractions

Frequently studied in cardiometabolic risk models.

4. Hepatic Fat & NAFLD Research

Tesamorelin has shown meaningful reductions in:

• Liver fat content

• Markers of hepatic steatosis

This makes it relevant to fatty liver disease and metabolic liver dysfunction research.

 

Research Context & Comparisons

Tesamorelin vs GH

• GH: Direct, continuous exposure

• Tesamorelin: Pulsatile, endogenous stimulation
  → Lower proliferative risk, more physiologic signaling

Tesamorelin vs GHRPs (Ipamorelin, GHRP-6)

• GHRPs act via ghrelin receptors

• Tesamorelin acts via GHRH receptors
  → More metabolic and visceral-fat–specific effects

 

Product Specifications

• Compound Name: Tesamorelin (TH9507)

• CAS Number: 218949-48-5

• Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S

• Molecular Weight: 5,135.86 Da

• Peptide Length: 29 amino acids

• Peptide Class: GHRH analog

• Purity: ≥98% (HPLC verified)

• Form: Lyophilized powder

• Appearance: White to off-white solid

• Storage: ≤ –20 °C, desiccated, protected from light

 

Batch Documentation & Traceability

Each vial is shipped with a lot-specific QR code that provides secure access to batch documentation, including:

• Certificate of Analysis (COA)
• Identity verification report (HPLC / MS)
• Lot number, potency, and expiration

Documentation is locked to the specific batch shipped to ensure traceability, version control, and research reproducibility.

QR access is provided with the physical product and is not reused across lots.

 

Research Use Disclaimer

This product is supplied exclusively for laboratory research use.
Not for human or veterinary use.
Not intended for diagnostic, therapeutic, or consumptive applications.